Servier and Google Cloud Expand Partnership on using Data and AI 
Enosi Life Sciences Files Patent for TNF-Inhibiting Molecules EN1001, EN2001 and EN3001
These therapeutics will benefit the treatment of multiple diseases including autoimmune diseases, acute inflammation and cancer SAN DIEGO, Nov. 18,...
AZTherapies Completes COGNITE Phase 3 Alzheimer’s Clinical Trial; Top-Line Data Readout Expected in First Quarter of 2021
Last Patient/Last Visit completed on November 13th enabling full clinical database lock BOSTON, Nov. 18, 2020 (GLOBE NEWSWIRE) -- AZTherapies,...
Todos Medical Announces Positive Initial Clinical Proof-of-Concept Data for a Rapid SARS-CoV-2 3CL Protease Detection Assay
NEW YORK, NY, REHOVAT, ISRAEL, SINGAPORE, Nov. 18, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical (OTCQB: TOMDF), an in vitro diagnostics company focused...
MediGO Announces Deployment of FlightAware Data to Enhance Organ Transportation Logistics
Companies form alliance to monitor organs transiting in air, the first of its kind BALTIMORE, Nov. 18, 2020 (GLOBE NEWSWIRE)...
Grey Cloak Tech Inc. Announces Strategic Equity Investment from the Medical Community
Four additional doctors have invested with Grey Cloak Tech, showing confidence in the effectiveness of the company’s proprietary heart and...
Generex Inks $50 Million Licensing Deal with China Partners on the Cooperative Development of the Ii-Key Vaccine Platform
$50 million licensing deal for the Ii-Key platform to develop vaccines for infectious diseases and cancer Deal includes first contract...
iRemedy™ Secures Factory Capacity for Needles and Syringes Required for Administration of One+ Billion COVID-19 Vaccinations
STUART, Fla., Nov. 18, 2020 (GLOBE NEWSWIRE) -- The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the...
KemPharm and Corium to Co-Host “KP415 Market Opportunity and Commercialization Strategy” Investor Event
Online Event Scheduled for Wednesday, December 2, 2020 at 10:00 a.m., ET CELEBRATION, Fla., Nov. 18, 2020 (GLOBE NEWSWIRE) --...
CorMedix Inc. Announces FDA Decision That Advisory Committee Meeting for New Drug Application for Defencath is Not Needed
PDUFA date remains February 28, 2021 Potentially the first antibacterial and antifungal catheter lock solution in the US to prevent...
Tenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. Announce Shareholder Meeting Date to Approve the Business Combination
NEW YORK and CUPERTINO, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Tenzing Acquisition Corp., a special purpose acquisition company incorporated...
ENZO BIOCHEM ANNOUNCES APPOINTMENT OF MARY TAGLIAFERRI, MD, TO ITS BOARD OF DIRECTORS
NEW YORK, NY, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “the Company”), a leading biosciences...
RVL Pharmaceuticals, Inc. Strengthens Leadership Team as Commercial Launch of Upneeq® Expands
-- Addition of Dr. Raymond Douglas, M.D., PhD, further enhances RVL’s commitment to advancing the clinical and scientific platform supporting...
SummerBio Launches High-Volume, Affordable Molecular Test to Detect COVID-19
- SummerBio streamlined and automated the entire process of high-quality RT-PCR testing to reduce cost and massively increase test volumes...
Shockwave Medical to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
SANTA CLARA, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of...
Inspire Medical Systems, Inc. to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
MINNEAPOLIS, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on...
Progyny Strengthens Board of Directors with Appointments of Healthcare and Technology Leaders
NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility...
Fortress Biotech Ranked in Deloitte’s Technology Fast 500™ for the Second Year in a Row
NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative revenue-generating company focused on...
KBP Biosciences Appoints Douglas Losordo Chief Medical Officer
PRINCETON, N.J., Nov. 18, 2020 (GLOBE NEWSWIRE) -- KBP Biosciences, a clinical-stage biotechnology company dedicated to research, development, and commercialization...
Kronos Bio Reports Recent Business Progress and Third Quarter 2020 Financial Results
Acquired from Gilead Sciences a portfolio of SYK inhibitors, including lead investigational therapy entospletinib being developed for frontline treatment of...
Enlivex Reports Positive Two-Year Clinical Outcome For A Hospitalized Patient with Erosive Osteoarthritis Treated with Allocetra
* Significant short and long-term clinical improvement for a hospitalized patient with a rare disease that currently has no effective...